Suchergebnisse - "Sun, Ryan"

PubPharm (137)

51

Inference for set‐based effects in genetic association studies with interval‐censored outcomes

enthalten in: Biometrics | 2023

von Sun, R. | Zhu, L. | Li, Y. | +2

52

Inference for set-based effects in genetic association studies with interval-censored outcomes

enthalten in: Biometrics | 2023

von Sun, R. | Zhu, L. | Li, Y. | +2

53

Quantifying Clinical Utility of Enzalutamide for Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Sun, R. | Wei, L.

CommentOn: J Clin Oncol. 2022 May 20;40(15):1616-1622. - PMID 35420921

54

A framework for detecting noncoding rare-variant associations of large-scale whole-genome sequencing studies

enthalten in: Nature methods | 2022

von Li, Z. | Li, X. | Zhou, H. | +167

CommentIn: Nat Methods. 2022 Dec;19(12):1532-1533. - PMID 36316564

55

Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy

enthalten in: Leukemia | 2022

von Strati, P. | Jallouk, A. | Sun, R. | +21

56

Quantifying Clinical Utility of Adjuvant Abemaciclib in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy

enthalten in: JAMA oncology | 2022

von Sun, R. | Wei, L.

CommentOn: JAMA Oncol. 2022 Aug 1;8(8):1190-1194. - PMID 35653145

57

Pembrolizumab in Triple-Negative Breast Cancer

enthalten in: The New England journal of medicine | 2022

von Sun, R. | Wei, L.

CommentOn: N Engl J Med. 2022 Jul 21;387(3):217-226. - PMID 35857659

58

Handling Informative Premature Treatment or Study Discontinuation for Assessing Between-Group Differences in a Comparative Oncology Trial

enthalten in: JAMA oncology | 2022

von Huang, B. | Sun, R. | Claggett, B. | +3

59

Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk

enthalten in: Human molecular genetics | 2022

von Li, Y. | Xiao, X. | Li, J. | +53

60

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma

enthalten in: Blood | 2022

von Cherng, H. | Sun, R. | Sugg, B. | +22

CommentIn: Blood. 2022 Aug 4;140(5):414-415. - PMID 35925642